LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/NYU Langone’s Ball Raises $1.3 Million+
Company News

NYU Langone’s Ball Raises $1.3 Million+

December 4, 2017 2 min read Premium comments

Advertisement

NYU Langone’s Ball Raises $1.3 Million+
Courtesy of NYU Langone Health
Secondary

NYU Langone Health, based in New York, New York, has an additional $1.3 million or so to put towards caring for patients. The source? A gala known as the annual Musculoskeletal Ball, this year held on November 14, 2017 at the American Museum of Natural History in Manhattan.

Chairing the event was Steven Yang, M.D., M.P.H., clinical professor of orthopedic surgery and director of clinical affairs, Division of Hand Surgery.

Robert I. Grossman, M.D., the Saul J. Farber Dean and CEO of NYU Langone said; “It’s a thrill to celebrate our first Musculoskeletal Ball as NYU Langone Orthopedic Hospital and NYU Langone Orthopedic Center. These new names reflect our continuing integration as an institution, and speak philosophically to our larger goal of providing a seamless continuum of care for our patients.”

Patrick A. Meere, M.D., was one of the evening’s honorees. Dr. Meere, who is a knee and hip surgeon and co-director of the orthopedic robotic surgery program, specializes in developing and using advanced techniques and emerging technologies, such as robotic-assisted surgery and sensors for smart implants. According to a spokesman for NYU, “He leads NYU Langone’s same day and rapid discharge initiative for people who require knee surgery. With the goal of improving care for his patients, Dr. Meere founded and co-leads the Advanced Arthroplasty Research Laboratory, where he studies joint replacement in collaboration with researchers at NYU Langone Orthopedic Hospital and faculty at the NYU Tandon School of Engineering.”

“Also honored was Tarek Sherif and his wife, Sophie Nicholson, for their support of a wide range of social causes including the International Women’s Health Coalition, Students on Ice, Partnership Fund for New York City, and Defy Ventures. Sophie and Tarek are also avid supporters of NYU Langone Orthopedic Hospital, where Tarek is a member of the Musculoskeletal Advisory Board.”

“A co-founder of Medidata Solutions, Tarek Sherif has served as CEO since 2001 and chairman since 2009. Tarek has led Medidata from startup to a leading global provider of cloud-based solutions for clinical research. Sophie Nicholson’s career has focused on the life sciences industry; clinical development was the focus of her efforts with Amgen, where she worked on novel cancer therapies.”

Joseph D. Zuckerman, M.D., the Walter A.L. Thompson Professor of Orthopedic Surgery and chair of the Department of Orthopedic Surgery at NYU Langone Health, told OTW, “The generosity of those attending the Musculoskeletal Ball will make it possible for NYU Langone Health’s Department of Orthopedic Surgery to continue to advance our efforts in robotic and sensor technology in knee and hip replacement, as well as to extend the impact of our multidisciplinary concussion program. The end result of these programs is improved patient care, which is the most important goal we have.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy